AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Axcelis Technologies, Inc.
Video analysis: ACLS
All videosNo video analysis for this stock yet. Request one from our team.
News: ACLS
Axcelis Announces Sponsorship and Participation in the 25th International Conference on Ion Implantation and Annealing Technology 2026
BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the International Conference on Ion Implantation and Annealing Technology 2026 (IIT 2026) taking place September 20-24 at the Congress Center Villach in Austria.
Axcelis Technologies Inc (ACLS) Shares Fall 3.0% -- GF Value Says Still Overvalued
On September 09, 2026, Axcelis Technologies Inc (ACLS) shares fell 3.0%, closing at $115.56. The stock has experienced volatility over the past year, with a 52-
Axcelis Technologies (ACLS) Declines More Than Market: Some Information for Investors
Axcelis Technologies (ACLS) closed the most recent trading day at $115.56, moving 3.03% from the previous trading session.
Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea
BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.
Axcelis Announces Participation in Upcoming Investor Conferences
BEVERLY, Mass., Sept. 1, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Citi 2026 Global TMT Conference on Tuesday, September 8th at the New York Hilton Midtown.
Is the Options Market Predicting a Spike in Axcelis Technologies Stock?
Investors need to pay close attention to ACLS stock based on the movements in the options market lately.
Is Axcelis Stock a Buy?
Business is accelerating at the perfect moment.
Cetera Investment Advisers Sells 4,828 Shares of Axcelis Technologies, Inc. $ACLS
Cetera Investment Advisers trimmed its position in Axcelis Technologies, Inc. (NASDAQ: ACLS) by 48.5% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 5,127 shares of the semiconductor company's stock after selling 4,828 shares during the period. Cetera Investment Advisers' holdings in Axcelis Technologies were